Distal Cholangiocarcinoma with Biliary Obstruction: After ERCP-Based Stenting Has Not Relieved Jaundice
This protocol applies to inoperable distal cholangiocarcinoma (not perihilar) with distal malignant tract obstruction causing obstructive jaundice, where the initial ERCP-based intervention — including self-expanding metal stent placement — did not achieve adequate reduction of jaundice or relief of biliary obstruction symptoms.
Inoperable distal cholangiocarcinoma, not perihilar, presenting with distal malignant biliary obstruction and obstructive jaundice. Stenting via ERCP has been attempted.
Combined EUS and ERCP, or standalone ERCP, with placement of a fully covered self-expanding metal stent (SEMS) was undertaken for palliation of jaundice. The goals of that line — meaningful reduction in the degree of jaundice and relief of symptoms from biliary obstruction — were not reached. This escalation addresses that unmet need.
References
DOI: 10.1136/gutjnl-2023-330029
Patients with DMTO with inoperable disease from distal CCA should undergo an EUS/ERCP or standalone ERCP to confirm a pathological diagnosis and have their jaundice palliated.
Where patients cannot have a stent placed at ERCP, we recommend EUS guided biliary drainage is undertaken rather than PTC.
However, PTC can be offered if EUS bile duct drainage is not locally available.
View source ↗